RBC Capital analyst Dan Leonard initiates coverage on 10X Genomics (NASDAQ: TXG) with a Sector Perform rating and a price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE